| Entry |
|
|---|
| Name |
Adrogolide hydrochloride (USAN) |
|---|
| Formula |
C22H25NO4S. HCl
|
|---|
| Exact mass |
435.1271
|
|---|
| Mol weight |
435.96
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
|
|---|
| Efficacy |
Antiparkinsonian, Dopamine D1 receptor agonist |
|---|
| Comment |
Ergot alkaloid
Treatment of the symptoms of Parkinson's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
D02775 Adrogolide hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D02775 Adrogolide hydrochloride (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 29
1 O7a O 14.8277 -19.2997
2 C7a C 13.5696 -19.9986
3 C1a C 13.5696 -21.3965
4 C1x C 12.3814 -15.1061
5 C1x C 12.3814 -13.7082
6 C1y C 13.5696 -13.0093
7 C1y C 14.8277 -13.7082
8 C8y C 14.8277 -15.1061
9 C8y C 13.5696 -15.8050
10 N1x N 13.5696 -11.6114
11 C1x C 14.8277 -10.9125
12 C8y C 16.0159 -11.6114
13 C8y C 16.0159 -13.0093
14 C8x C 16.0159 -15.8050
15 C8y C 16.0159 -17.2029
16 C8y C 14.8277 -17.9018
17 C8x C 13.5696 -17.2029
18 O6a O 18.4622 -15.8050
19 C7a C 18.4622 -17.2029
20 O7a O 17.2041 -17.9018
21 S2x S 17.3439 -11.1920
22 C8y C 18.1826 -12.3103
23 C8x C 17.3439 -13.4286
24 C1a C 19.6503 -17.9018
25 O6a O 12.3814 -19.2997
26 C1b C 19.3708 -11.6114
27 C1b C 20.6289 -12.3103
28 C1a C 21.8171 -11.6114
29 X Cl 24.8225 -16.9932
BOND 31
1 1 2 1
2 2 3 1
3 4 5 1
4 5 6 1
5 6 7 1
6 7 8 1
7 8 9 1
8 4 9 1
9 6 10 1
10 10 11 1
11 11 12 1
12 12 13 2
13 7 13 1
14 8 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 9 2
19 18 19 2
20 19 20 1
21 15 20 1
22 12 21 1
23 21 22 1
24 22 23 2
25 13 23 1
26 19 24 1
27 1 16 1
28 25 2 2
29 22 26 1
30 26 27 1
31 27 28 1
|
|---|
